RCEL

RCEL Operating Income Growth

24.65%TTM

Period ending:

RCEL TTM Operating Income YoY %%
RCEL TTM Operating Income YoY %87.31%-143.18%
2013-12-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

RCEL operating income growth history

Year-over-year operating income growth rate. The available trailing twelve months (ttm) series contains 51 observations from Dec 31, 2013 to Jun 30, 2026.

Avita Medical Inc Operating Income Growth — Trailing twelve months (TTM)
Period endingOperating Income Growth
24.6459%
22.8492%
24.8388%
28.5593%
14.0988%
-2.5305%
-32.6761%
-62.3285%
-66.2257%
-78.8464%
-55.0809%
-20.6811%
-8.1263%
2.3939%
-9.5031%
-34.9989%
-14.0618%
17.915%
53.6887%
65.0012%
55.7593%
46.5542%
6.2201%
-21.874%
-7.1214%
-15.3519%
-22.9779%
-20.7512%
-45.5846%
-120.8712%
-104.1195%
-103.6122%
-97.0683%
-45.9644%
-47.6633%
-44.5637%
-41.5454%
-41.7914%
-43.0907%
-50.6214%
-58.6194%
-56.1563%
-52.1462%
-38.2991%
-23.6271%
-1.2788%
16.9598%
21.3754%
22.191%
20.5793%
18.8778%

Compare operating income growth

All RCEL financial metrics · RCEL stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.